Intentar ORO - Gratis

Analytical instrument & pharma spectroscopy equipment

Chronicle Pharmabiz

|

October 16, 2025

THE analytical instrument is a device that enables analytical measurements to be carried out automatically and objectively. It helps analysts to work out composition, characterize samples, separate mixtures, yield useful and accurate results.

- P Mandal

The instruments are often broken down into component parts such as electronic signal modifier, e.g. filter or amplifier; signal generator, e.g. radiation source; input transducer/detector; and output transducer, e.g. computer. The instruments measure critical process parameters such as pH, conductivity in a wide variety of applications for reliable monitoring.

Applications of analytical instruments are connected with a variety of fields not only in laboratory areas, but also in areas such as pharmaceutical analysis; materials characterization and research; life science research of metabolomics, genomics, proteomics; and clinical analysis.

An analytical scientist should have precise knowledge about various types of analytical instruments, analytical procedures, principles and techniques as well as a strong theoretical knowledge of the fundamental science behind them. This enables critical thinking and an understanding behind the techniques used, something that distinguishes the analytical scientist's difference from other scientists.

Analytical scientists also need to be able to critically evaluate an issue or problem held up and decide on the best course of action taking into account time people and sample turnaround, cost, availability of people and instruments, accuracy and knowledge of any knock-on effects or consequences that the result will have and this is the analytical procedure.

Analytical method development

Analytical method development involves the evaluation and selection of the most precise assay procedures to determine the composition of a drug. Thus, analytical method development and validation is tremendously important for a drug development programme.

Analytical procedures are developed to test specific characteristics of the substances against the predefined acceptance criteria for characteristics.

MÁS HISTORIAS DE Chronicle Pharmabiz

Chronicle Pharmabiz

US FDA fortifies alliance with Telangana DCA

A high-level delegation from the US FDA concluded a significant meeting with the DCA in Telangana, two days ago, at the DCA office in Hyderabad.

time to read

2 mins

December 11, 2025

Chronicle Pharmabiz

India exploring possibilities to expand WHO standards for Indian medicines

INDIA is looking at possibilities to expand the World Health Organisation (WHO) global benchmarking standards for medicines, in order to unify and strengthen the drug regulatory mechanism for safety, quality and efficacy of medicines sold in the country.

time to read

1 min

December 11, 2025

Chronicle Pharmabiz

Eli Lilly gets US FDA approval for Jaypirca

Eli Lilly and Company announced that the US Food and Drug Administration (FDA) has granted approval to Jaypirca (pirtobrutinib, 100 mg & 50 mg tablets) for the treatment of adults with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma (CLL/SLL) who have previously been treated with a covalent Bruton tyrosine kinase (BTK) inhibitor.

time to read

1 mins

December 11, 2025

Chronicle Pharmabiz

Haryana DCA focuses on quality overhaul

THE Haryana drug control administration (DCA) is undertaking a major organizational overhaul focused on quality system upgrades and regulatory capacity building, particularly in response to the revised Schedule M norms.

time to read

2 mins

December 11, 2025

Chronicle Pharmabiz

DoC seeks inputs on trade issues faced with Japan

THE Department of Commerce (DoC), under the Union Commerce Ministry, has sought inputs from the industry on specific issues being faced in pharma trade with Japan.

time to read

1 min

December 11, 2025

Chronicle Pharmabiz

AIOCD asks traders to strictly comply with ban on 35 FDCs

THE All India Organisation of Chemists and Druggists (AIOCD) has issued an urgent internal circular to all its state and Union territory trade bodies, demanding immediate and strict compliance with the ban on 35 fixed dose combinations (FDCs).

time to read

3 mins

December 11, 2025

Chronicle Pharmabiz

US FDA approves Bristol Myers Squibb's Breyanzi

Bristol Myers Squibb announced that the US Food and Drug Administration (FDA) has granted approval of Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment of adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL) who have received at least two prior lines of systemic therapy.

time to read

2 mins

December 11, 2025

Chronicle Pharmabiz

CN Water presents AQU@Sense MB

CN Water is now combining core water-system expertise with digital assurance has launched AQU@Sense which delivers microbial test results in under 30 minutes, replacing traditional 5 to 7 days culture based methods.

time to read

1 min

December 11, 2025

Chronicle Pharmabiz

Pharma logistics sees policy push as key catalyst for growth

INDIAN pharma's logistics sector is getting major boost from emerging policy support.

time to read

2 mins

December 11, 2025

Chronicle Pharmabiz

Lack of financial aid, expertise mar MSME prospects to meet revised Sch M deadline

INDUSTRY experts have raised alarm that lack of financial assistance and guidance on technical expertise have marred pharma MSMEs’ prospects to comply with revised Schedule M guidelines of December 31, 2025.

time to read

2 mins

December 11, 2025

Listen

Translate

Share

-
+

Change font size